Your browser doesn't support javascript.
loading
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.
Mehlman, Camille; Cadranel, Jacques; Rousseau-Bussac, Gaelle; Lacave, Roger; Pujals, Anaïs; Girard, Nicolas; Callens, Céline; Gounant, Valérie; Théou-Anton, Nathalie; Friard, Sylvie; Trédaniel, Jean; Blons, Hélène; Dujon, Cécile; Duchemann, Boris; Schischmanoff, Pierre Olivier; Chinet, Thierry; Giroux Leprieur, Etienne.
Afiliación
  • Mehlman C; Department of Respiratory Diseases and Thoracic Oncology, APHP - Hopital Ambroise Pare, EA 4340 BECCOH, UVSQ, Paris Saclay University, Boulogne-Billancourt, France.
  • Cadranel J; Chest Department-Thoracic Oncology Expert Center, AP-HP, Groupe Hospitalier HUEP, Hopital Tenon, Paris, France, and Sorbonne University, Paris, France.
  • Rousseau-Bussac G; Chest Departement, Creteil Intercommunal Hospital, Créteil, France.
  • Lacave R; Department of Solide Tumours Genetic, AP-HP, Groupe Hospitalier HUEP, Tenon Hospital, Paris, France, and Sorbonne University, Paris, France.
  • Pujals A; Department of Pathology, Henri Mondor Hospital, AP-HP, Créteil, France.
  • Girard N; Thorax Institute, Institute Curie and PSL University, Paris, France.
  • Callens C; Department of Genetics, Institut Curie, Paris, France.
  • Gounant V; Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, AP-HP, Paris, France.
  • Théou-Anton N; Genetics Department, University Hospital Bichat-Claude Bernard, AP-HP, Paris, France.
  • Friard S; Pneumology Department, Foch Hospital, Suresnes, France.
  • Trédaniel J; Pneumology Department, Saint-Joseph Hospital, Paris, France.
  • Blons H; Molecular Biology Department, Georges Pompidou European Hospital, AP- HP, Paris, France and INSERM UMR-S1147, CNRS SNC 5014, Saints-Pères Research Center, Paris-Descartes University, Sorbonne Paris Cité University, Paris, France.
  • Dujon C; Pneumology Department, André Mignot Hospital, Le Chesnay, France.
  • Duchemann B; Oncology Department, Avicenne Hospital, AP-HP, Bobigny, France and Paris XIII University, Sorbonne Paris Cité, Paris, France and Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US 23 INSERM, Gustave Roussy Cancer Campus, Villejuif, France.
  • Schischmanoff PO; Department of Molecular Oncogenetics, Avicenne Hospital, AP-HP, Bobigny, France and INSERM UMR U978/Paris XIII University, Sorbonne Paris Cité University, Paris, France.
  • Chinet T; Department of Respiratory Diseases and Thoracic Oncology, APHP - Hopital Ambroise Pare, EA 4340 BECCOH, UVSQ, Paris Saclay University, Boulogne-Billancourt, France.
  • Giroux Leprieur E; Department of Respiratory Diseases and Thoracic Oncology, APHP - Hopital Ambroise Pare, EA 4340 BECCOH, UVSQ, Paris Saclay University, Boulogne-Billancourt, France. Electronic address: etienne.giroux-leprieur@aphp.fr.
Lung Cancer ; 137: 149-156, 2019 11.
Article en En | MEDLINE | ID: mdl-31600593
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Acrilamidas / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Compuestos de Anilina / Neoplasias Pulmonares / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Acrilamidas / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Compuestos de Anilina / Neoplasias Pulmonares / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article